DaVita Inc. (NYSE:DVA) Shares Sold by TIAA Trust National Association

Key Points

• TIAA Trust National Association has significantly reduced its holdings in DaVita Inc. by 69.2%, now owning only 2,021 shares valued at $309,000 after selling 4,532 shares in the first quarter.
• Several institutional investors, including UMB Bank and Copia Wealth Management, increased their stakes in DaVita during the same period, illustrating mixed investor sentiment towards the company.
• Analysts have recently upgraded DaVita from a "hold" to a "buy" rating, whilst others have set varying price targets, indicating ongoing market interest in the stock's potential.

TIAA Trust National Association lessened its stake in shares of DaVita Inc. (NYSE:DVA - Free Report) by 69.2% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 2,021 shares of the company's stock after selling 4,532 shares during the period. TIAA Trust National Association's holdings in DaVita were worth $309,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also added to or reduced their stakes in the company. United Capital Financial Advisors LLC lifted its stake in shares of DaVita by 2.6% during the 4th quarter. United Capital Financial Advisors LLC now owns 2,416 shares of the company's stock worth $361,000 after acquiring an additional 62 shares during the last quarter. Freedom Investment Management Inc. increased its stake in DaVita by 3.6% in the fourth quarter. Freedom Investment Management Inc. now owns 1,790 shares of the company's stock worth $268,000 after purchasing an additional 62 shares during the period. Wealth Enhancement Advisory Services LLC boosted its stake in shares of DaVita by 2.0% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 3,551 shares of the company's stock valued at $531,000 after purchasing an additional 69 shares during the period. UMB Bank n.a. grew its holdings in shares of DaVita by 65.5% in the first quarter. UMB Bank n.a. now owns 192 shares of the company's stock worth $29,000 after purchasing an additional 76 shares during the last quarter. Finally, Exchange Traded Concepts LLC increased its stake in DaVita by 8.9% in the 1st quarter. Exchange Traded Concepts LLC now owns 970 shares of the company's stock worth $148,000 after buying an additional 79 shares during the period. Institutional investors own 90.12% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on DVA shares. Barclays lowered their target price on DaVita from $169.00 to $160.00 and set an "equal weight" rating for the company in a report on Thursday. Wall Street Zen raised DaVita from a "hold" rating to a "buy" rating in a research report on Friday, April 25th. Finally, Truist Financial decreased their price objective on shares of DaVita from $170.00 to $164.00 and set a "hold" rating for the company in a research report on Monday, May 19th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, DaVita has a consensus rating of "Hold" and a consensus target price of $165.60.

Insider Activity

In other news, insider James O. Hearty sold 2,351 shares of the company's stock in a transaction on Wednesday, July 23rd. The shares were sold at an average price of $150.00, for a total transaction of $352,650.00. Following the completion of the sale, the insider owned 26,038 shares of the company's stock, valued at $3,905,700. This represents a 8.28% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 2.00% of the stock is owned by corporate insiders.

DaVita Price Performance

DaVita stock traded down $0.21 during trading on Thursday, reaching $127.61. The company had a trading volume of 1,120,881 shares, compared to its average volume of 864,031. The firm has a market capitalization of $9.12 billion, a PE ratio of 12.55, a price-to-earnings-growth ratio of 0.88 and a beta of 1.09. The firm's 50-day simple moving average is $140.15 and its 200 day simple moving average is $147.07. The company has a debt-to-equity ratio of 23.18, a quick ratio of 1.20 and a current ratio of 1.39. DaVita Inc. has a 1-year low of $126.07 and a 1-year high of $179.60.

DaVita (NYSE:DVA - Get Free Report) last released its earnings results on Tuesday, August 5th. The company reported $2.95 EPS for the quarter, topping analysts' consensus estimates of $2.70 by $0.25. DaVita had a net margin of 6.35% and a return on equity of 369.39%. The business had revenue of $3.38 billion during the quarter, compared to analysts' expectations of $3.36 billion. During the same quarter in the previous year, the company earned $2.00 earnings per share. The company's quarterly revenue was up 6.1% on a year-over-year basis. As a group, equities research analysts anticipate that DaVita Inc. will post 10.76 earnings per share for the current fiscal year.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.